Kuwait’s Burgan Eyes Pharma Investment in Uzbekistan

Director of the Uzbek Pharmaceutical Industry Development Agency, Abdullah Azizov, has held talks with representatives of Kuwait-based Burgan International, focusing on potential investment in Uzbekistan’s fast-growing pharmaceutical sector.

Founded in 1993, Burgan International is a global contracting and manufacturing company active in oil, energy, and infrastructure projects, with total assets estimated at $8 billion, The Caspian Post reports via Uzbek media.

During the meeting, the company proposed establishing a large-scale production facility for injectable and oncology medicines within the Tashkent Pharma Park. The delegation presented a phased roadmap for implementing the project.

Azizov briefed the guests on Uzbekistan’s current pharmaceutical legislation, tax incentives, and the broad range of opportunities available to investors operating in the Pharma Park. Officials emphasized that the project would enable Burgan International to access markets across the Commonwealth of Independent States, while also holding strategic importance for the country’s pharmaceutical industry.

At the conclusion of the meeting, both sides expressed readiness to deepen cooperation. The Agency confirmed its full support for the initiative and agreed to continue negotiations on the project’s next steps.